https://www.selleckchem.com/pr....oducts/Elesclomol.ht
Prospectively scored radiation pneumonitis (RP) observed in a national, randomized phase II dose-escalation trial for patients with locally advanced non-small cell lung cancer (NSCLC) was investigated. Patients with stage IIB-IIIB histologically proven NSCLC were treated with concomitant chemo-radiotherapy (oral Vinorelbine 3times/week) at 60Gy/30fx (A-59pts) and 66Gy/33fx (B-58pts) from 2009 to 2013 at five Danish RT centers. Grade 2 RP (CTCAEv3. was investigated with univariate analysis for association with clinical and dosimetri
Like
Comment
Share
